Compare Bio Protocol (BIO) vs Venus (XVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Venus — how do they compare? Bio Protocol trades at Rp513.9 (market cap Rp1,15T, Rp260,42M 24h volume), while Venus trades at Rp49,011 (market cap Rp788,21M, Rp99,95M 24h volume). The key difference: Bio Protocol is far larger — about 1459× Venus's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Venus's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Venus for 39 Days on average.
| BIO | XVS | |
|---|---|---|
Market Cap | Rp1,15T | Rp788,21M |
Volume (24h) | Rp260,42M | Rp99,95M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 16,4M XVS |
Typical Hold Time | 16 Days | 39 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Venus (XVS) is currently trading at Rp48,298 with a market cap of Rp788.7 million, showing a bullish technical signal overall despite overbought RSI readings. The asset is positioned above key support levels with strong moving average alignment. Recent on-chain activity indicates moderate holder accumulation with an average hold time of 39 days, though specific protocol updates remain limited according to current data.
Overall outlook suggests cautious optimism with technical strength counterbalanced by overbought conditions. Key opportunities include potential breakout above resistance zones, while major risks involve high volatility and limited liquidity depth. Investors should monitor RSI cooling and ecosystem developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Venus
Venus (XVS) is an algorithmic money market and synthetic stablecoin protocol launched exclusively on Binance Smart Chain (BSC). The protocol introduces a simple-to-use crypto asset lending and borrowing solution to the decentralized finance (DeFi) ecosystem, enabling users to directly borrow against collateral at high speed while losing less to transaction fees.
Read more on XVS →
